COVID-19 Project Topics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
* [[Cardiovascular Disorders and COVID-19]] | * [[Cardiovascular Disorders and COVID-19]] | ||
* [[Dermatologic Disorders of COVID-19]] | * [[Dermatologic Disorders of COVID-19]] | ||
* Hematologic disorders and COVID-19 | *[[Hematologic disorders and COVID-19]] | ||
* [[Nephrologic Disorders and COVID-19]] | * [[Nephrologic Disorders and COVID-19]] | ||
* [[Neurologic Disorders and COVID-19]] | * [[Neurologic Disorders and COVID-19]] | ||
Revision as of 14:15, 11 June 2020
| COVID-19 Project |
|---|
| Introduction |
| Team |
| Meetings' Summary |
| Topics |
| Ongoing Clinical Trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Overview
Select a Topic
List of All Topics
- Cardiovascular Disorders and COVID-19
- Dermatologic Disorders of COVID-19
- Hematologic disorders and COVID-19
- Nephrologic Disorders and COVID-19
- Neurologic Disorders and COVID-19
- Ongoing Clinical Trials of COVID-19
- Pulmonary Disorders and COVID-19
- Pediatrics and COVID-19
- Radiologic Manifestations of COVID-19